Nonsense-mediated mRNA decay: Inter-individual variability and human disease

Neuroscience and Biobehavioral Reviews

Volumn 46, Issue P2, 2014, Pages 175-186

  Nguyen, Lam Son ^a   Wilkinson, Miles F ^b   Gecz, Jozef ^a,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Institute of Genomic Medicine University of California ^*  (Australia)

Author keywords

Copy number variation; Expression quantitative trait loci; Inter individual NMD efficiency; MiR 125; MiR 128; Nonsense mediated mRNA decay; Regulation of NMD; Staufen mediated mRNA decay

Indexed keywords

MESSENGER RNA; MICRORNA; MYOGENIN; TRANSCRIPTOME;

CUTIS LAXA; DECISION MAKING; ENVIRONMENTAL FACTOR; GASTROINTESTINAL MALFORMATION; GENE; GENE EXPRESSION; GENETIC DISORDER; GENETIC VARIABILITY; HEREDITY; HUMAN; INTELLECTUAL IMPAIRMENT; LTBP4 GENE; MENTAL DISEASE; MISSENSE MUTATION; NEGATIVE FEEDBACK; NONHUMAN; NONSENSE MEDIATED MRNA DECAY; PHENOTYPE; POPULATION GENETICS; PREMATURE TERMINATION CODON; QUANTITATIVE TRAIT LOCUS; RBM8A GENE; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STOP CODON; UPF2 GENE; UPF3A GENE; UPF3B GENE; ANIMAL; BIOLOGICAL MODEL; GENETICS;

ANIMALS; GENETIC DISEASES, INBORN; GENETIC VARIATION; HUMANS; MODELS, GENETIC; NONSENSE MEDIATED MRNA DECAY; TRANSCRIPTOME;

EID: 84909642803     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.10.016     Document Type: Review

References (144)

1. Addington A.M., Gauthier J., Piton A., Hamdan F.F., Raymond A., Gogtay N., Miller R., Tossell J., Bakalar J., Germain G., Gochman P., Long R., Rapoport J.L., Rouleau G.A. A novel frameshift mutation in UPF3B identified in brothers affected with childhood onset schizophrenia and autism spectrum disorders. Mol. Psychiatry 2011, 16:238-239.
2. Alachkar A., Jiang D., Harrison M., Zhou Y., Chen G., Mao Y. An EJC factor RBM8a regulates anxiety behaviors. Curr. Mol. Med. 2013, 13:887-899.
3. Albers C.A., Paul D.S., Schulze H., Freson K., Stephens J.C., Smethurst P.A., Jolley J.D., Cvejic A., Kostadima M., Bertone P., Breuning M.H., Debili N., Deloukas P., Favier R., Fiedler J., Hobbs C.M., Huang N., Hurles M.E., Kiddle G., Krapels I., Nurden P., Ruivenkamp C.A., Sambrook J.G., Smith K., Stemple D.L., Strauss G., Thys C., van Geet C., Newbury-Ecob R., Ouwehand W.H., Ghevaert C. Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat. Genet. 2012, 44:435-439.
4. Applequist S.E., Selg M., Raman C., Jack H.M. Cloning and characterization of HUPF1, a human homolog of the Saccharomyces cerevisiae nonsense mRNA-reducing UPF1 protein. Nucleic Acids Res. 1997, 25:814-821.
5. Baguet A., Degot S., Cougot N., Bertrand E., Chenard M.P., Wendling C., Kessler P., Le Hir H., Rio M.C., Tomasetto C. The exon-junction-complex-component metastatic lymph node 51 functions in stress-granule assembly. J. Cell Sci. 2007, 120:2774-2784.
6. Baumann B., Potash M.J., Kohler G. Consequences of frameshift mutations at the immunoglobulin heavy chain locus of the mouse. EMBO J. 1985, 4:351-359.
7. Bono F., Ebert J., Unterholzner L., Guttler T., Izaurralde E., Conti E. Molecular insights into the interaction of PYM with the Mago-Y14 core of the exon junction complex. EMBO Rep. 2004, 5:304-310.
8. Bruno I.G., Karam R., Huang L., Bhardwaj A., Lou C.H., Shum E.Y., Song H.W., Corbett M.A., Gifford W.D., Gecz J., Pfaff S.L., Wilkinson M.F. Identification of a MicroRNA that activates gene expression by repressing nonsense-mediated RNA decay. Mol. Cell 2011, 42:500-510.
9. Buhler M., Paillusson A., Muhlemann O. Efficient downregulation of immunoglobulin mu mRNA with premature translation-termination codons requires the 5'-half of the VDJ exon. Nucleic Acids Res. 2004, 32:3304-3315.
10. Cali B.M., Kuchma S.L., Latham J., Anderson P. smg-7 is required for mRNA surveillance in Caenorhabditis elegans. Genetics 1999, 151:605-616.
11. Callewaert B., Su C.T., Van Damme T., Vlummens P., Malfait F., Vanakker O., Schulz B., Mac Neal M., Davis E.C., Lee J.G., Salhi A., Unger S., Heimdal K., De Almeida S., Kornak U., Gaspar H., Bresson J.L., Prescott K., Gosendi M.E., Mansour S., Pierard G.E., Madan-Khetarpal S., Sciurba F.C., Symoens S., Coucke P.J., Van Maldergem L., Urban Z., De Paepe A. Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa. Hum. Mutat. 2013, 34:111-121.
12. Castagne R., Zeller T., Rotival M., Szymczak S., Truong V., Schillert A., Tregouet D.A., Munzel T., Ziegler A., Cambien F., Blankenberg S., Tiret L. Influence of sex and genetic variability on expression of X-linked genes in human monocytes. Genomics 2011, 98:320-326.
13. Chan C.C., Dostie J., Diem M.D., Feng W., Mann M., Rappsilber J., Dreyfuss G. eIF4A3 is a novel component of the exon junction complex. RNA 2004, 10:200-209.
14. Chan W.K., Bhalla A.D., Le Hir H., Nguyen L.S., Huang L., Gecz J., Wilkinson M.F. A UPF3-mediated regulatory switch that maintains RNA surveillance. Nat. Struct. Mol. Biol. 2009, 16:747-753.
15. Chan W.K., Huang L., Gudikote J.P., Chang Y.F., Imam J.S., MacLean J.A., Wilkinson M.F. An alternative branch of the nonsense-mediated decay pathway. EMBO J. 2007, 26:1820-1830.
16. Chiu S.Y., Serin G., Ohara O., Maquat L.E. Characterization of human Smg5/7a: a protein with similarities to Caenorhabditis elegans SMG5 and SMG7 that functions in the dephosphorylation of Upf1. RNA 2003, 9:77-87.
17. Cooper G.M., Coe B.P., Girirajan S., Rosenfeld J.A., Vu T.H., Baker C., Williams C., Stalker H., Hamid R., Hannig V., Abdel-Hamid H., Bader P., McCracken E., Niyazov D., Leppig K., Thiese H., Hummel M., Alexander N., Gorski J., Kussmann J., Shashi V., Johnson K., Rehder C., Ballif B.C., Shaffer L.G., Eichler E.E. A copy number variation morbidity map of developmental delay. Nat. Genet. 2011, 43:838-846.
18. Degot S., Le Hir H., Alpy F., Kedinger V., Stoll I., Wendling C., Seraphin B., Rio M.C., Tomasetto C. Association of the breast cancer protein MLN51 with the exon junction complex via its speckle localizer and RNA binding module. J. Biol. Chem. 2004, 279:33702-33715.
19. Denning G., Jamieson L., Maquat L.E., Thompson E.A., Fields A.P. Cloning of a novel phosphatidylinositol kinase-related kinase: characterization of the human SMG-1 RNA surveillance protein. J. Biol. Chem. 2001, 276:22709-22714.
20. Dixon A.L., Liang L., Moffatt M.F., Chen W., Heath S., Wong K.C., Taylor J., Burnett E., Gut I., Farrall M., Lathrop G.M., Abecasis G.R., Cookson W.O. A genome-wide association study of global gene expression. Nat. Genet. 2007, 39:1202-1207.
21. Eberle A.B., Lykke-Andersen S., Muhlemann O., Jensen T.H. SMG6 promotes endonucleolytic cleavage of nonsense mRNA in human cells. Nat. Struct. Mol. Biol. 2009, 16:49-55.
22. Fribourg S., Gatfield D., Izaurralde E., Conti E. A novel mode of RBD-protein recognition in the Y14-Mago complex. Nat. Struct. Biol. 2003, 10:433-439.
23. Frischmeyer P.A., Dietz H.C. Nonsense-mediated mRNA decay in health and disease. Hum. Mol. Genet. 1999, 8:1893-1900.
24. Fu J., Wolfs M.G., Deelen P., Westra H.J., Fehrmann R.S., Te Meerman G.J., Buurman W.A., Rensen S.S., Groen H.J., Weersma R.K., van den Berg L.H., Veldink J., Ophoff R.A., Snieder H., van Heel D., Jansen R.C., Hofker M.H., Wijmenga C., Franke L. Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet. 2012, 8:e1002431.
25. Fukuhara N., Ebert J., Unterholzner L., Lindner D., Izaurralde E., Conti E. SMG7 is a 14-3-3-like adaptor in the nonsense-mediated mRNA decay pathway. Mol. Cell 2005, 17:537-547.
26. Gardner L.B. Hypoxic inhibition of nonsense-mediated RNA decay regulates gene expression and the integrated stress response. Mol. Cell. Biol. 2008, 28:3729-3741.
27. Gardner L.B. Nonsense-mediated RNA decay regulation by cellular stress: implications for tumorigenesis. Mol. Cancer Res. 2010, 8:295-308.
28. Gehring N.H., Kunz J.B., Neu-Yilik G., Breit S., Viegas M.H., Hentze M.W., Kulozik A.E. Exon-junction complex components specify distinct routes of nonsense-mediated mRNA decay with differential cofactor requirements. Mol. Cell 2005, 20:65-75.
29. Gehring N.H., Lamprinaki S., Hentze M.W., Kulozik A.E. The hierarchy of exon-junction complex assembly by the spliceosome explains key features of mammalian nonsense-mediated mRNA decay. PLoS Biol. 2009, 7:e1000120.
30. Gehring N.H., Lamprinaki S., Kulozik A.E., Hentze M.W. Disassembly of exon junction complexes by PYM. Cell 2009, 137:536-548.
31. Gehring N.H., Neu-Yilik G., Schell T., Hentze M.W., Kulozik A.E. Y14 and hUpf3b form an NMD-activating complex. Mol. Cell 2003, 11:939-949.
32. Girirajan S., Eichler E.E. Phenotypic variability and genetic susceptibility to genomic disorders. Hum. Mol. Genet. 2010, 19:R176-R187.
33. Gong C., Kim Y.K., Woeller C.F., Tang Y., Maquat L.E. SMD and NMD are competitive pathways that contribute to myogenesis: effects on PAX3 and myogenin mRNAs. Genes Dev. 2009, 23:54-66.
34. Gulsuner S., Walsh T., Watts A.C., Lee M.K., Thornton A.M., Casadei S., Rippey C., Shahin H., Nimgaonkar V.L., Go R.C.P., Savage R.M., Swerdlow N.R., Gur R.E., Braff D.L., King M.-C., McClellan J.M. Spatial and temporal mapping of de novo mutations in Schizophrenia to a fetal prefrontal cortical network. Cell 2013, 154:518-529.
35. He F., Jacobson A. Identification of a novel component of the nonsense-mediated mRNA decay pathway by use of an interacting protein screen. Genes Dev. 1995, 9:437-454.
36. He F., Li X., Spatrick P., Casillo R., Dong S., Jacobson A. Genome-wide analysis of mRNAs regulated by the nonsense-mediated and 5' to 3' mRNA decay pathways in yeast. Mol. Cell 2003, 12:1439-1452.
37. Hodgkin J., Papp A., Pulak R., Ambros V., Anderson P. A new kind of informational suppression in the nematode Caenorhabditis elegans. Genetics 1989, 123:301-313.
38. Holbrook J.A., Neu-Yilik G., Hentze M.W., Kulozik A.E. Nonsense-mediated decay approaches the clinic. Nat. Genet. 2004, 36:801-808.
39. Horikawa Y., Oda N., Cox N.J., Li X., Orho-Melander M., Hara M., Hinokio Y., Lindner T.H., Mashima H., Schwarz P.E., del Bosque-Plata L., Oda Y., Yoshiuchi I., Colilla S., Polonsky K.S., Wei S., Concannon P., Iwasaki N., Schulze J., Baier L.J., Bogardus C., Groop L., Boerwinkle E., Hanis C.L., Bell G.I. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 2000, 26:163-175.
40. Hosoda N., Kim Y.K., Lejeune F., Maquat L.E. CBP80 promotes interaction of Upf1 with Upf2 during nonsense-mediated mRNA decay in mammalian cells. Nat. Struct. Mol. Biol. 2005, 12:893-901.
41. Huang L., Lou C.H., Chan W., Shum E.Y., Shao A., Stone E., Karam R., Song H.W., Wilkinson M.F. RNA homeostasis governed by cell type-specific and branched feedback loops acting on NMD. Mol. Cell 2011, 43:950-961.
42. Huang L., Wilkinson M.F. Regulation of nonsense-mediated mRNA decay. Wiley Interdiscip. Rev. RNA 2012, 3:807-828.
43. Huntzinger E., Kashima I., Fauser M., Sauliere J., Izaurralde E. SMG6 is the catalytic endonuclease that cleaves mRNAs containing nonsense codons in metazoan. RNA 2008, 14:2609-2617.
44. Isken O., Kim Y.K., Hosoda N., Mayeur G.L., Hershey J.W., Maquat L.E. Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay. Cell 2008, 133:314-327.
45. Jolly L.A., Homan C.C., Jacob R., Barry S., Gecz J. The UPF3B gene, implicated in intellectual disability, autism, ADHD and childhood onset schizophrenia regulates neural progenitor cell behaviour and neuronal outgrowth. Hum. Mol. Genet. 2013, (Epub ahead of print).
46. Kadlec J., Izaurralde E., Cusack S. The structural basis for the interaction between nonsense-mediated mRNA decay factors UPF2 and UPF3. Nat. Struct. Mol. Biol. 2004, 11:330-337.
47. Karam R., Wengrod J., Gardner L.B., Wilkinson M.F. Regulation of nonsense-mediated mRNA decay: implications for physiology and disease. Biochim. Biophys. Acta 2013, 1829:624-633.
48. Kashima I., Jonas S., Jayachandran U., Buchwald G., Conti E., Lupas A.N., Izaurralde E. SMG6 interacts with the exon junction complex via two conserved EJC-binding motifs (EBMs) required for nonsense-mediated mRNA decay. Genes Dev. 2010, 24:2440-2450.
49. Kashima I., Yamashita A., Izumi N., Kataoka N., Morishita R., Hoshino S., Ohno M., Dreyfuss G., Ohno S. Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay. Genes Dev. 2006, 20:355-367.
50. Kataoka N., Diem M.D., Kim V.N., Yong J., Dreyfuss G. Magoh, a human homolog of Drosophila mago nashi protein, is a component of the splicing-dependent exon-exon junction complex. EMBO J. 2001, 20:6424-6433.
51. Kataoka N., Yong J., Kim V.N., Velazquez F., Perkinson R.A., Wang F., Dreyfuss G. Pre-mRNA splicing imprints mRNA in the nucleus with a novel RNA-binding protein that persists in the cytoplasm. Mol. Cell 2000, 6:673-682.
52. Kebaara B.W., Atkin A.L. Long 3'-UTRs target wild-type mRNAs for nonsense-mediated mRNA decay in Saccharomyces cerevisiae. Nucleic Acids Res. 2009, 37:2771-2778.
53. Keeling K.M., Bedwell D.M. Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases. Wiley Interdiscip. Rev. RNA 2011, 2:837-852.
54. Kerem E., Hirawat S., Armoni S., Yaakov Y., Shoseyov D., Cohen M., Nissim-Rafinia M., Blau H., Rivlin J., Aviram M., Elfring G.L., Northcutt V.J., Miller L.L., Kerem B., Wilschanski M. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 2008, 372:719-727.
55. Kerenyi Z., Merai Z., Hiripi L., Benkovics A., Gyula P., Lacomme C., Barta E., Nagy F., Silhavy D. Inter-kingdom conservation of mechanism of nonsense-mediated mRNA decay. EMBO J. 2008, 27:1585-1595.
56. Kerr T.P., Sewry C.A., Robb S.A., Roberts R.G. Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?. Hum. Genet. 2001, 109:402-407.
57. Khajavi M., Inoue K., Lupski J.R. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur. J. Hum. Genet. 2006, 14:1074-1081.
58. Kim V.N., Kataoka N., Dreyfuss G. Role of the nonsense-mediated decay factor hUpf3 in the splicing-dependent exon-exon junction complex. Science 2001, 293:1832-1836.
59. Kim V.N., Yong J., Kataoka N., Abel L., Diem M.D., Dreyfuss G. The Y14 protein communicates to the cytoplasm the position of exon-exon junctions. EMBO J. 2001, 20:2062-2068.
60. Kim Y.K., Furic L., Desgroseillers L., Maquat L.E. Mammalian Staufen1 recruits Upf1 to specific mRNA 3'UTRs so as to elicit mRNA decay. Cell 2005, 120:195-208.
61. Kim Y.K., Furic L., Parisien M., Major F., DesGroseillers L., Maquat L.E. Staufen1 regulates diverse classes of mammalian transcripts. EMBO J. 2007, 26:2670-2681.
62. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39:D152-D157.
63. Kunz J.B., Neu-Yilik G., Hentze M.W., Kulozik A.E., Gehring N.H. Functions of hUpf3a and hUpf3b in nonsense-mediated mRNA decay and translation. RNA 2006, 12:1015-1022.
64. Lareau L.F., Inada M., Green R.E., Wengrod J.C., Brenner S.E. Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 2007, 446:926-929.
65. Lau C.K., Diem M.D., Dreyfuss G., Van Duyne G.D. Structure of the Y14-Magoh core of the exon junction complex. Curr. Biol. 2003, 13:933-941.
66. Laumonnier F., Nguyen L.S., Jolly L., Raynaud M., Gecz J. The role of the UPF3B gene and nonsense-mediated mRNA decay in Autism Spectrum Disorders. The Comprehensive Guide to Autism 2013, Springer. V.B. Patel, V.R. Preedy, C.R. Marin (Eds.).
67. Laumonnier F., Shoubridge C., Antar C., Nguyen L.S., Van Esch H., Kleefstra T., Briault S., Fryns J.P., Hamel B., Chelly J., Ropers H.H., Ronce N., Blesson S., Moraine C., Gecz J., Raynaud M. Mutations of the UPF3B gene, which encodes a protein widely expressed in neurons, are associated with nonspecific mental retardation with or without autism. Mol. Psychiatry 2010, 15:767-776.
68. Le Hir H., Gatfield D., Izaurralde E., Moore M.J. The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J. 2001, 20:4987-4997.
69. Le Hir H., Izaurralde E., Maquat L.E., Moore M.J. The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J. 2000, 19:6860-6869.
70. Leeds P., Peltz S.W., Jacobson A., Culbertson M.R. The product of the yeast UPF1 gene is required for rapid turnover of mRNAs containing a premature translational termination codon. Genes Dev. 1991, 5:2303-2314.
71. Leeds P., Wood J.M., Lee B.S., Culbertson M.R. Gene products that promote mRNA turnover in Saccharomyces cerevisiae. Mol. Cell. Biol. 1992, 12:2165-2177.
72. Lejeune F., Ishigaki Y., Li X., Maquat L.E. The exon junction complex is detected on CBP80-bound but not eIF4E-bound mRNA in mammalian cells: dynamics of mRNP remodeling. EMBO J. 2002, 21:3536-3545.
73. Lejeune F., Li X., Maquat L.E. Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities. Mol. Cell 2003, 12:675-687.
74. Linde L., Boelz S., Nissim-Rafinia M., Oren Y.S., Wilschanski M., Yaacov Y., Virgilis D., Neu-Yilik G., Kulozik A.E., Kerem E., Kerem B. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. J. Clin. Invest. 2007, 117:683-692.
75. Linde L., Kerem B. Introducing sense into nonsense in treatments of human genetic diseases. Trends Genet. 2008, 24:552-563.
76. Longman D., Plasterk R.H., Johnstone I.L., Caceres J.F. Mechanistic insights and identification of two novel factors in the C. elegans NMD pathway. Genes Dev. 2007, 21:1075-1085.
77. Lykke-Andersen J., Shu M.D., Steitz J.A. Human Upf proteins target an mRNA for nonsense-mediated decay when bound downstream of a termination codon. Cell 2000, 103:1121-1131.
78. Lykke-Andersen J., Shu M.D., Steitz J.A. Communication of the position of exon-exon junctions to the mRNA surveillance machinery by the protein RNPS1. Science 2001, 293:1836-1839.
79. Lynch S.A., Nguyen L.S., Ng L.Y., Waldron M., McDonald D., Gecz J. Broadening the phenotype associated with mutations in UPF3B: two further cases with renal dysplasia and variable developmental delay. Eur. J. Med. Genet. 2012, 55:476-479.
80. MacArthur D.G., Balasubramanian S., Frankish A., Huang N., Morris J., Walter K., Jostins L., Habegger L., Pickrell J.K., Montgomery S.B., Albers C.A., Zhang Z.D., Conrad D.F., Lunter G., Zheng H., Ayub Q., DePristo M.A., Banks E., Hu M., Handsaker R.E., Rosenfeld J.A., Fromer M., Jin M., Mu X.J., Khurana E., Ye K., Kay M., Saunders G.I., Suner M.M., Hunt T., Barnes I.H., Amid C., Carvalho-Silva D.R., Bignell A.H., Snow C., Yngvadottir B., Bumpstead S., Cooper D.N., Xue Y., Romero I.G., Wang J., Li Y., Gibbs R.A., McCarroll S.A., Dermitzakis E.T., Pritchard J.K., Barrett J.C., Harrow J., Hurles M.E., Gerstein M.B., Tyler-Smith C. A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012, 335:823-828.
81. MacDonald M.R., Schaefer G.B., Olney A.H., Patton D.F. Hypoplasia of the cerebellar vermis and corpus callosum in thrombocytopenia with absent radius syndrome on MRI studies. Am. J. Med. Genet. 1994, 50:46-50.
82. Maderazo A.B., He F., Mangus D.A., Jacobson A. Upf1p control of nonsense mRNA translation is regulated by Nmd2p and Upf3p. Mol. Cell. Biol. 2000, 20:4591-4603.
83. Mahowald G.K., Mahowald M.A., Moon C., Khor B., Sleckman B.P. Out-of-frame T cell receptor beta transcripts are eliminated by multiple pathways in vivo. PLoS ONE 2011, 6:e21627.
84. Makeyev E.V., Zhang J., Carrasco M.A., Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell 2007, 27:435-448.
85. Malan V., Rajan D., Thomas S., Shaw A.C., Louis Dit Picard H., Layet V., Till M., van Haeringen A., Mortier G., Nampoothiri S., Puseljic S., Legeai-Mallet L., Carter N.P., Vekemans M., Munnich A., Hennekam R.C., Colleaux L., Cormier-Daire V. Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome. Am. J. Hum. Genet. 2010, 87:189-198.
86. Maquat L.E., Gong C. Gene expression networks: competing mRNA decay pathways in mammalian cells. Biochem. Soc. Trans. 2009, 37:1287-1292.
87. McElroy S.P., Nomura T., Torrie L.S., Warbrick E., Gartner U., Wood G., McLean W.H. A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays. PLoS Biol. 2013, 11:e1001593.
88. McIlwain D.R., Pan Q., Reilly P.T., Elia A.J., McCracken S., Wakeham A.C., Itie-Youten A., Blencowe B.J., Mak T.W. Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12186-12191.
89. Medghalchi S.M., Frischmeyer P.A., Mendell J.T., Kelly A.G., Lawler A.M., Dietz H.C. Rent1, a trans-effector of nonsense-mediated mRNA decay, is essential for mammalian embryonic viability. Hum. Mol. Genet. 2001, 10:99-105.
90. Mendell J.T., Medghalchi S.M., Lake R.G., Noensie E.N., Dietz H.C. Novel Upf2p orthologues suggest a functional link between translation initiation and nonsense surveillance complexes. Mol. Cell. Biol. 2000, 20:8944-8957.
91. Mendell J.T., Sharifi N.A., Meyers J.L., Martinez-Murillo F., Dietz H.C. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat. Genet. 2004, 36:1073-1078.
92. Metze S., Herzog V.A., Ruepp M.D., Muhlemann O. Comparison of EJC-enhanced and EJC-independent NMD in human cells reveals two partially redundant degradation pathways. RNA 2013, 19:1432-1448.
93. Morita T., Yamashita A., Kashima I., Ogata K., Ishiura S., Ohno S. Distant N- and C-terminal domains are required for intrinsic kinase activity of SMG-1, a critical component of nonsense-mediated mRNA decay. J. Biol. Chem. 2007, 282:7799-7808.
94. Nagy E., Maquat L.E. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem. Sci. 1998, 23:198-199.
95. Nazarenus T., Cedarberg R., Bell R., Cheatle J., Forch A., Haifley A., Hou A., Wanja Kebaara B., Shields C., Stoysich K., Taylor R., Atkin A.L. Upf1p, a highly conserved protein required for nonsense-mediated mRNA decay, interacts with the nuclear pore proteins Nup100p and Nup116p. Gene 2005, 345:199-212.
96. Nguyen L.S., Jolly L., Shoubridge C., Chan W.K., Huang L., Laumonnier F., Raynaud M., Hackett A., Field M., Rodriguez J., Srivastava A.K., Lee Y., Long R., Addington A.M., Rapoport J.L., Suren S., Hahn C.N., Gamble J., Wilkinson M.F., Corbett M.A., Gecz J. Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability. Mol. Psychiatry 2012, 17:1103-1115.
97. Nguyen L.S., Kim H.G., Rosenfeld J.A., Shen Y., Gusella J.F., Lacassie Y., Layman L.C., Shaffer L.G., Gecz J. Contribution of copy number variants involving nonsense-mediated mRNA decay pathway genes to neuro-developmental disorders. Hum. Mol. Genet. 2013, 22:1816-1825.
98. Nicholson P., Yepiskoposyan H., Metze S., Zamudio Orozco R., Kleinschmidt N., Muhlemann O. Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell. Mol. Life Sci. 2010, 67:677-700.
99. Ohnishi T., Yamashita A., Kashima I., Schell T., Anders K.R., Grimson A., Hachiya T., Hentze M.W., Anderson P., Ohno S. Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes containing hSMG-5 and hSMG-7. Mol. Cell 2003, 12:1187-1200.
100. Okada-Katsuhata Y., Yamashita A., Kutsuzawa K., Izumi N., Hirahara F., Ohno S. N- and C-terminal Upf1 phosphorylations create binding platforms for SMG-6 and SMG-5:SMG-7 during NMD. Nucleic Acids Res. 2012, 40:1251-1266.
101. Okamura K. Diversity of animal small RNA pathways and their biological utility. Wiley Interdiscip. Rev. RNA 2012, 3:351-368.
102. Page M.F., Carr B., Anders K.R., Grimson A., Anderson P. SMG-2 is a phosphorylated protein required for mRNA surveillance in Caenorhabditis elegans and related to Upf1p of yeast. Mol. Cell. Biol. 1999, 19:5943-5951.
103. Palacios I.M., Gatfield D., St Johnston D., Izaurralde E. An eIF4AIII-containing complex required for mRNA localization and nonsense-mediated mRNA decay. Nature 2004, 427:753-757.
104. Park E., Gleghorn M.L., Maquat L.E. Staufen2 functions in Staufen1-mediated mRNA decay by binding to itself and its paralog and promoting UPF1 helicase but not ATPase activity. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:405-412.
105. Perlick H.A., Medghalchi S.M., Spencer F.A., Kendzior R.J., Dietz H.C. Mammalian orthologues of a yeast regulator of nonsense transcript stability. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:10928-10932.
106. Pulak R., Anderson P. mRNA surveillance by the Caenorhabditis elegans smg genes. Genes Dev. 1993, 7:1885-1897.
107. Rehwinkel J., Letunic I., Raes J., Bork P., Izaurralde E. Nonsense-mediated mRNA decay factors act in concert to regulate common mRNA targets. RNA 2005, 11:1530-1544.
108. Resta N., Susca F.C., Di Giacomo M.C., Stella A., Bukvic N., Bagnulo R., Simone C., Guanti G. A homozygous frameshift mutation in the ESCO2 gene: evidence of intertissue and interindividual variation in Nmd efficiency. J. Cell. Physiol. 2006, 209:67-73.
109. Rosenfeld J.A., Traylor R.N., Schaefer G.B., McPherson E.W., Ballif B.C., Klopocki E., Mundlos S., Shaffer L.G., Aylsworth A.S. Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes. Eur. J. Hum. Genet. 2012, 20:754-761.
110. Ruiz-Echevarria M.J., Peltz S.W. The RNA binding protein Pub1 modulates the stability of transcripts containing upstream open reading frames. Cell 2000, 101:741-751.
111. Saul H., Elharrar E., Gaash R., Eliaz D., Valenci M., Akua T., Avramov M., Frankel N., Berezin I., Gottlieb D., Elazar M., David-Assael O., Tcherkas V., Mizrachi K., Shaul O. The upstream open reading frame of the Arabidopsis AtMHX gene has a strong impact on transcript accumulation through the nonsense-mediated mRNA decay pathway. Plant J. 2009, 60:1031-1042.
112. Sauliere J., Haque N., Harms S., Barbosa I., Blanchette M., Le Hir H. The exon junction complex differentially marks spliced junctions. Nat. Struct. Mol. Biol. 2010, 17:1269-1271.
113. Sauliere J., Murigneux V., Wang Z., Marquenet E., Barbosa I., Le Tonqueze O., Audic Y., Paillard L., Roest Crollius H., Le Hir H. CLIP-seq of eIF4AIII reveals transcriptome-wide mapping of the human exon junction complex. Nat. Struct. Mol. Biol. 2012, 19:1124-1131.
114. Schoenberg D.R., Maquat L.E. Regulation of cytoplasmic mRNA decay. Nat. Rev. Genet. 2012, 13:246-259.
115. Schweingruber C., Rufener S.C., Zund D., Yamashita A., Muhlemann O. Nonsense-mediated mRNA decay - mechanisms of substrate mRNA recognition and degradation in mammalian cells. Biochim. Biophys. Acta 2013, 1829:612-623.
116. Serin G., Gersappe A., Black J.D., Aronoff R., Maquat L.E. Identification and characterization of human orthologues to Saccharomyces cerevisiae Upf2 protein and Upf3 protein (Caenorhabditis elegans SMG-4). Mol. Cell. Biol. 2001, 21:209-223.
117. Shi H., Xu R.M. Crystal structure of the Drosophila mago nashi-Y14 complex. Genes Dev. 2003, 17:971-976.
118. Silva A.L., Pereira F.J., Morgado A., Kong J., Martins R., Faustino P., Liebhaber S.A., Romao L. The canonical UPF1-dependent nonsense-mediated mRNA decay is inhibited in transcripts carrying a short open reading frame independent of sequence context. RNA 2006, 12:2160-2170.
119. Silver D.L., Watkins-Chow D.E., Schreck K.C., Pierfelice T.J., Larson D.M., Burnetti A.J., Liaw H.J., Myung K., Walsh C.A., Gaiano N., Pavan W.J. The exon junction complex component Magoh controls brain size by regulating neural stem cell division. Nat. Neurosci. 2010, 13:551-558.
120. Singh G., Kucukural A., Cenik C., Leszyk J.D., Shaffer S.A., Weng Z., Moore M.J. The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. Cell 2012, 151:750-764.
121. Singh K.K., Wachsmuth L., Kulozik A.E., Gehring N.H. Two mammalian MAGOH genes contribute to exon junction complex composition and nonsense-mediated decay. RNA Biol. 2013, 10:1291-1298.
122. Stranger B.E., Montgomery S.B., Dimas A.S., Parts L., Stegle O., Ingle C.E., Sekowska M., Smith G.D., Evans D., Gutierrez-Arcelus M., Price A., Raj T., Nisbett J., Nica A.C., Beazley C., Durbin R., Deloukas P., Dermitzakis E.T. Patterns of cis regulatory variation in diverse human populations. PLoS Genet. 2012, 8:e1002639.
123. Tani H., Imamachi N., Salam K.A., Mizutani R., Ijiri K., Irie T., Yada T., Suzuki Y., Akimitsu N. Identification of hundreds of novel UPF1 target transcripts by direct determination of whole transcriptome stability. RNA Biol. 2012, 9:1370-1379.
124. Tarpey P.S., Nguyen L.S., Raymond F.L., Rodriguez J., Hackett A., Vandeleur L., Smith R., Shoubridge C., Edkins S., Stevens C., O'Meara S., Tofts C., Barthorpe S., Buck G., Cole J., Halliday K., Hills K., Jones D., Mironenko T., Perry J., Varian J., West S., Widaa S., Teague J., Dicks E., Butler A., Menzies A., Richardson D., Jenkinson A., Shepherd R., Raine K., Moon J., Luo Y., Parnau J., Bhat S.S., Gardner A., Corbett M., Brooks D., Thomas P., Parkinson-Lawrence E., Porteous M.E., Warner J.P., Sanderson T., Pearson P., Simensen R.J., Skinner C., Hoganson G., Superneau D., Wooster R., Bobrow M., Turner G., Stevenson R.E., Schwartz C.E., Futreal P.A., Srivastava A.K., Stratton M.R., Gecz J. Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation. Nat. Genet. 2007, 39:1127-1133.
125. Thomson D.W., Bracken C.P., Goodall G.J. Experimental strategies for microRNA target identification. Nucleic Acids Res. 2011, 39:6845-6853.
126. Unterholzner L., Izaurralde E. SMG7 acts as a molecular link between mRNA surveillance and mRNA decay. Mol. Cell 2004, 16:587-596.
127. Voineagu I. Gene expression studies in autism: moving from the genome to the transcriptome and beyond. Neurobiol. Dis. 2012, 45:69-75.
128. Wang D., Wengrod J., Gardner L.B. Overexpression of the c-myc oncogene inhibits nonsense-mediated RNA decay in B lymphocytes. J. Biol. Chem. 2011, 286:40038-40043.
129. Wang D., Zavadil J., Martin L., Parisi F., Friedman E., Levy D., Harding H., Ron D., Gardner L.B. Inhibition of nonsense-mediated RNA decay by the tumor microenvironment promotes tumorigenesis. Mol. Cell. Biol. 2011, 31:3670-3680.
130. Wang G., Jiang B., Jia C., Chai B., Liang A. MicroRNA 125 represses nonsense-mediated mRNA decay by regulating SMG1 expression. Biochem. Biophys. Res. Commun. 2013, 435:16-20.
131. Wang J., Gudikote J.P., Olivas O.R., Wilkinson M.F. Boundary-independent polar nonsense-mediated decay. EMBO Rep. 2002, 3:274-279.
132. Wang J., Vock V.M., Li S., Olivas O.R., Wilkinson M.F. A quality control pathway that down-regulates aberrant T-cell receptor (TCR) transcripts by a mechanism requiring UPF2 and translation. J. Biol. Chem. 2002, 277:18489-18493.
133. Weischenfeldt J., Damgaard I., Bryder D., Theilgaard-Monch K., Thoren L.A., Nielsen F.C., Jacobsen S.E., Nerlov C., Porse B.T. NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. Genes Dev. 2008, 22:1381-1396.
134. Weischenfeldt J., Waage J., Tian G., Zhao J., Damgaard I., Jakobsen J.S., Kristiansen K., Krogh A., Wang J., Porse B.T. Mammalian tissues defective in nonsense-mediated mRNA decay display highly aberrant splicing patterns. Genome Biol. 2012, 13:R35.
135. Welch E.M., Barton E.R., Zhuo J., Tomizawa Y., Friesen W.J., Trifillis P., Paushkin S., Patel M., Trotta C.R., Hwang S., Wilde R.G., Karp G., Takasugi J., Chen G., Jones S., Ren H., Moon Y.C., Corson D., Turpoff A.A., Campbell J.A., Conn M.M., Khan A., Almstead N.G., Hedrick J., Mollin A., Risher N., Weetall M., Yeh S., Branstrom A.A., Colacino J.M., Babiak J., Ju W.D., Hirawat S., Northcutt V.J., Miller L.L., Spatrick P., He F., Kawana M., Feng H., Jacobson A., Peltz S.W., Sweeney H.L. PTC124 targets genetic disorders caused by nonsense mutations. Nature 2007, 447:87-91.
136. Welch E.M., Jacobson A. An internal open reading frame triggers nonsense-mediated decay of the yeast SPT10 mRNA. EMBO J. 1999, 18:6134-6145.
137. Wittmann J., Hol E.M., Jack H.M. hUPF2 silencing identifies physiologic substrates of mammalian nonsense-mediated mRNA decay. Mol. Cell. Biol. 2006, 26:1272-1287.
138. Wu L., Candille S.I., Choi Y., Xie D., Jiang L., Li-Pook-Than J., Tang H., Snyder M. Variation and genetic control of protein abundance in humans. Nature 2013, 499:79-82.
139. Xu X., Zhang L., Tong P., Xun G., Su W., Xiong Z., Zhu T., Zheng Y., Luo S., Pan Y., Xia K., Hu Z. Exome sequencing identifies UPF3B as the causative gene for a Chinese non-syndrome mental retardation pedigree. Clin. Genet. 2013, 83:560-564.
140. Yamashita A., Izumi N., Kashima I., Ohnishi T., Saari B., Katsuhata Y., Muramatsu R., Morita T., Iwamatsu A., Hachiya T., Kurata R., Hirano H., Anderson P., Ohno S. SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate remodeling of the mRNA surveillance complex during nonsense-mediated mRNA decay. Genes Dev. 2009, 23:1091-1105.
141. Yamashita A., Ohnishi T., Kashima I., Taya Y., Ohno S. Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay. Genes Dev. 2001, 15:2215-2228.
142. Yepiskoposyan H., Aeschimann F., Nilsson D., Okoniewski M., Muhlemann O. Autoregulation of the nonsense-mediated mRNA decay pathway in human cells. RNA 2011, 17:2108-2118.
143. Zetoune A.B., Fontaniere S., Magnin D., Anczukow O., Buisson M., Zhang C.X., Mazoyer S. Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues. BMC Genet. 2008, 9:83.
144. Zhao X.F., Nowak N.J., Shows T.B., Aplan P.D. MAGOH interacts with a novel RNA-binding protein. Genomics 2000, 63:145-148.